Patients Denied Life Saving Organ Transplants Health

New Post Public Reply Private Reply Replies (0) Message Board
CherylShuman

Patients Denied Life Saving Organ Transplants

Health Tragedy: Patients Denied Life-Saving Transplants for Their "Abuse of Illicit Substances"

Let's end the needless discrimination against desperately ill cannabis consumers.

Medical marijuana activists like to claim that cannabis has never killed anyone. While it is true that cannabis is remarkably non-toxic ("the safest therapeutically-active substance known to man," according to a DEA judge), medical marijuana use has actually killed many people in the United States.

For in the now fourteen states that allow legal medicinal use of cannabis, a registered patient in need of a life-saving organ transplant will be disqualified for "abuse of illicit substances." For people like Tim Garon of Seattle, that was a death sentence.

Recently the Los Angeles City Council held hearings on the thorny issue of medical marijuana dispensary regulation. For years city officials have abrogated their duty to create sensible regulations for the dispensaries that have proliferated across the Los Angeles basin. The number of dispensaries has ballooned to over 500 ( not the 1,000+ often claimed ) following an ineffective moratorium on the retail medical marijuana outlets.

As usual, the hearings were packed, with medical marijuana patients and activists flooding the chambers to add their testimony to the record. One citizen petitioning her government for a redress of grievances was the Executive Director of the new Beverly Hills NORML 90210 (http://www.norml90210.org/become-a-member.php), Cheryl Shuman. In sixty seconds of testimony, Cheryl recounts her own personal medical marijuana tragedy, one that has befallen many desperately ill patients who use cannabis -- even legally -- and require life-saving organ transplants:

Cheryl's case is not unique. All across America, hospitals are booting patients off of organ transplant lists because of their use of cannabis. Being a legal user of cannabis for medicinal purposes in the now fourteen states that recognize that right is of no help; even legal medical marijuana patients are essentially given a death sentence by hospital and insurance bureaucracies for their use of a safe, non-toxic herbal remedy.

Timothy Garon was a Seattle musician who had contracted Hepatitis C. Garon was on a waiting list for a life-saving liver transplant. The state of Washington recognizes Hep C as a qualifying condition for the medical use of cannabis. Garon's physician, Dr. Brad Roter, authorized Garon to smoke pot to alleviate his nausea and abdominal pain and to stimulate his appetite while he awaited. Garon had become dangerously thin and malnourished and the cannabis therapy helped bring him back from the brink of death.

But unbeknown to Dr. Roter, hospital transplant programs have strict rules that forbid "substance abusers" from qualifying for organ transplants. Seattle's University of Washington Medical Center told Garon that if he ceased his marijuana use and tested clean for 60 days, he could have his liver transplant. Another medical center specified six months of marijuana abstinence before they'd save his life with surgery.

Doctors had told Garon he had about two weeks to live and he died on May 1, 2008. The cruelest irony is that cannabis is one of the few therapies Garon could have taken for pain and nausea that is not hepatoxic (liver-killing) and laden with a list of other nasty side effects.

In Hawaii, Kimberley Reyes suffered from cirrhosis and hepatitis and was given thirty days to live. She applied for and received approval for a life-saving liver transplant, only to have the rug pulled out from under her three days later when her insurance company, Hawaii Medical Service Association, discovered cannabis in her system, which she had used to relieve feelings of nausea, disorientation and pain. Ten days later she, too, was dead.

In Washington, Jonathan Simchen suffers from kidney failure . Doctors at Virginia Mason and University of Washington medical centers deny him a life-saving kidney transplant because of his participation in the Washington State medical marijuana program. According to Alisha Mark, a spokeswoman for Virginia Mason, "any patient who smokes any product -- tobacco, cloves, medical marijuana -- would be precluded from receiving a transplant here."

In Georgia, a man named Walter emailed me after reading these transplant stories:

My name is Walter and my kidney transplant was denied by Blue Cross Blue Shield of Georgia due to the fact I smoke marijuana.

In January I went to the University of Minnesota/Fairview Transplant Center for an evaluation. In order to be completely honest with all the doctors I made them aware of the fact that I smoke marijuana and have for quite some time. I also made them aware that the use of marijuana has helped me with the decline of my appetite due to end stage of renal disease . With the exception of the hospital shrink, no one seemed to have a problem with it and even commented that my smoking had nothing to do with my kidney.

Blue Cross Blue Shield approved the evaluation but [after] having received the paperwork from Minnesota has declined my transplant, stating "Kidney transplantation has not been shown to be more beneficial than other alternative treatments for patients with ongoing substance abuse. Thus, I recommended denial of kidney transplantation" (Ronald Hunt MD - Medical Director).

Jim Klahr is a well-known medical marijuana activist here in Oregon who also suffers from cirrhosis and hepatitis C. In an ironic twist, he sits on the state's advisory committee on medical marijuana, yet hasn't used his most effective medicine for his pain and nausea since 2004 because he's terrified of losing his chance for a liver transplant. "I've capitulated because basically I don't have much of a choice," says Klahr. Paul Stanford of The Hemp & Cannabis Foundation , the state's largest medical marijuana clinic, estimates at least 30 Oregonians who use medical weed have died in the past 10 years after hospitals denied them new organs.

We understand why hospitals have strict qualifying criteria for transplant candidates. Transplant organs are in high demand and doctors want every recipient to have the best chance at survival possible. Hospitals screen their transplant lists for "substance abusers" because it really doesn't make much sense to put a new liver into an alcoholic who will just go out and drink that organ into cirrhosis and failure as well. It's foolhardy to give a new kidney to a heroin addict who would then possibly share needles and come down with another life-threatening disease.

But in the case of cannabis users, the concern for the chance of post-transplant survival is misplaced. According to new research at the University of Michigan , cannabis use has no impact on the long-term survival rates of liver transplant recipients. After studying 1,489 liver transplant patients, 155 of whom were cannabis users, over a span of eight years, researchers concluded, " Patients who did and did not use marijuana had similar survival rates. Current substance abuse policies do not seem to systematically expose marijuana users to additional risk of mortality."

The cases of Cheryl Shuman and all these victims of a cruel and needless discrimination against desperately ill cannabis consumers illustrate why existing medical marijuana laws, while commendable, do not go far enough. Cheryl Shuman, Tim Garon, Jim Klahr and others are all legal medical marijuana patients in their state, yet powerless under the law to force hospitals to keep them on the transplant lists. This discrimination exists because cannabis is considered an "illicit drug of abuse" in the same category as heroin and LSD. This is why cannabis must be removed from Schedule I, legalized for prescription by any doctor in any state, so that it may truly be treated like other medicines, including the prohibition on discrimination against a transplant patient for the use of his or her doctor's prescriptions.

"Radical" Russ Belville is the Outreach Coordinator for the National Organization for the Reform of Marijuana Laws in Washington DC. He hosts "NORML SHOW LIVE", a 60-minute news and interviews program for the cannabis community every weekday at 4pm Eastern athttp://live.norml.org, archive and blog available at http://stash.norml.org.

Original Link:  http://www.alternet.org/story/145432/health_tragedy%3A_patients_denied_life-saving_transplants_for_their_%22abuse_of_illicit_substances%22

Rapid Fire Marketing, Inc. (RFMK) Stock Research Links

RFMK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 89

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 211

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
DJI Puts 3D Conservation Tools to Work Across Segovia

Updated Category News Views 146

Stone monuments do not care about marketing slogans; they care whether somebody notices the crack before winter gets hold of it. That is why DJI’s World Heritage 3D Conservation Initiative in Segovia lands as more than a shiny drone-company ceremony. The company gathered winning 3D fly-through work from its first initiative, but the useful bit was the case for turning...

Continue Reading
Vanguard's Digital Win Matters More Than a Trophy

Updated Category News Views 182

A wealth manager’s website rarely earns applause, but a bad one can sure as hell lose trust fast. Vanguard’s move to No. 1 from No. 3 in the 2025 ranking for advised-investor website satisfaction is worth noticing because it hits the unglamorous part of wealth management that clients actually live with: checking accounts, understanding a plan, moving cash, and...

Continue Reading
V2’s FOAS Bets on Candid Ad Sales Operator Dialogue

Updated Category News Views 200

Ad sales rarely gets fixed by another ballroom panel, and V2 seems to know it. Its new Future of Ad Sales, or FOAS, forum is built around a simpler premise: put senior operators in a small room, keep vendors and conference theatrics out of the way, and let people compare the ugly real-world details of running revenue machines. Announced November 19, 2026, FOAS is an...

Continue Reading
ACOLT Bets on Gold, Craft, and a Sci-Fi Story World

Updated Category News Views 96

A gold pendant moonlighting as a plot device is not the usual luxury pitch, and thank goodness for that. ACOLT, the Denver-based men's fine jewelry house founded by Colton Hindle, plans an international December 2026 launch of its Gold Collection alongside CHRYSON Volume 1: The Arrival, an original science-fiction comic. The actual hand-forged pieces are meant to show up...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 70

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading
Sailun’s COP31 Pitch Rests on Tire Tech and Hard Proof

Updated Category News Views 64

Antalya Put Tire Chemistry on a Very Public Stage Rubber tires rarely get a starring role at a climate summit, which is exactly why Sailun Group’s appearance at COP31 deserves a closer look. From November 9 through 20 in Antalya, Türkiye, Chairwoman Yanhua Liu used the United Nations climate gathering to lay out the company’s case: better tire technology can cut...

Continue Reading
Trip.com Sets December 1 Date for Third-Quarter Results

Updated Category News Views 122

December’s first after-hours session will put Trip.com Group back under the market’s microscope, whether anybody is ready or not. The company says it will report results for the three months ended September 30, 2026 after the U.S. market closes on Tuesday, December 1. That is the whole hard-news payload for now: a reporting date, a call time, and no numbers to get...

Continue Reading
Shareholder Votes Clear ODNB-NACB Merger's Final Hurdle

Updated Category News Views 69

A merger vote rarely makes anyone pound the table, but it does remove one very real way a bank deal can stumble. ODNB Financial Corporation and National Capital Bancorp, Inc. have announced that their shareholders approved the proposed merger. That is meaningful progress, plain and simple. It says the owners who get to live with the outcome have signed off on joining the...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Evolving Preferences of Chinese Consumers

Updated Category News Views 550

Understanding Chinese Consumer Dynamics In recent years, the landscape of consumer behavior in China has evolved dramatically. The once rigid stereotypes associated with Chinese shoppers have begun to fade as they embrace a wider array of goods. From handmade products to those imported from abroad, the acceptance of diverse choices has become a defining feature of this...

Continue Reading
Huntington Bancshares Announces Dividend Payments for Stocks

Updated Category News Views 110

Huntington Bancshares Declares Quarterly Cash Dividends Huntington Bancshares Incorporated has made headlines recently as the Board of Directors declared a quarterly cash dividend for its common stock, marked at $0.155 per common share. This amount remains unchanged from the previous quarter, showcasing the company’s steady commitment to delivering value to its...

Continue Reading
German American Completes Merger with Heartland Bancorp

Updated Category News Views 198

German American Completes Merger with Heartland Bancorp German American Bancorp, Inc. (Nasdaq: GABC) has successfully completed its merger with Heartland BancCorp, which is the parent company of Heartland Bank. This merger took effect at 12:01 a.m. (Eastern time) on a recent day. Following the merger, Heartland Bank has merged with German American’s banking subsidiary,...

Continue Reading
Frederick Visitor Center's Exciting Renovations Near Completion

Updated Category News Views 295

Frederick Visitor Center Closes for Final Renovations Visit Frederick has announced that the Frederick Visitor Center will temporarily close to finalize ongoing renovations. This brief closure period is from March 3 to 7, and it is aimed at implementing new exhibits designed to enhance the overall visitor experience. Temporary Visitor Center Services During this closure,...

Continue Reading
Nvidia's Revolutionary AI Chip Surges Amid Insatiable Demand

Updated Category News Views 187

Nvidia's AI Breakthrough: The Rise of Blackwell Nvidia’s next-generation artificial intelligence chip, known as Blackwell, is now in full production. CEO Jensen Huang has stated that the demand for these chips is overwhelming, with many companies eager to be at the forefront of AI technology. Huang’s Insights on Demand During a recent appearance on CNBC, Huang...

Continue Reading